Sun Pharma settles patent litigation with Celgene Corporation for cancer drug Revlimid

Drug major Sun Pharma has reached an agreement with Celgene Corporation, to resolve the patent litigation regarding generic version of Revlimid (lenalidomide capsules) in the US. Revlimid is used in the treatment of cancer.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news